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Abstract
Prevention of mother-to-child transmission (PMTCT) interventions reduce the cumulative
probability of transmission from a HIV positive woman to her child by as much as 40 percentage
points. This paper is the rst economic analysis of the behavioral eects of PMTCT. I examine
fertility responses to the scale-up of PMTCT in Zambia, a country where approximately 15
percent of adults age 15-49 are HIV positive. My results suggest that the local introduction of
PMTCT reduced pregnancy rates by up to 20 percent, that the fertility response was greater
among women who were more likely to be HIV positive, and that PMTCT substantially in-
creased breastfeeding rates.
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Prevention of mother-to-child transmission (PMTCT) interventions are a highly eective method
of preventing new HIV infections. Approximately 10 percent of new HIV infections occur through
mother-to-child transmission (De Cock et al 2000). A HIV positive woman may transmit the disease
in utero, during childbirth, or to a child while breastfeeding. PMTCT reduces the cumulative
probability of transmission from as much as 45 percent in the absence of PMTCT to as little as 3
percent (Dabis and Ekpini 2002, Canning 2006).
In the past decade, Zambia has dramatically expanded access to subsidized PMTCT at antenatal
clinics.1 The number of hospitals and clinics oering PMTCT has risen from fewer than 6 sites in
2000 to nearly 600 sites (or roughly 40 percent of health sites) by the end of 2007. Although the
medical eects of PMTCT in this setting are well-documented (e.g., Stringer et al 2003, Stringer
et al 2005), there is little research on the behavioral eects of this expansion.
This paper examines fertility responses to PMTCT scale-up in Zambia. In a country where
more than 15 percent of adults age 15-49 are HIV positive, the availability of PMTCT changes the
incentives women and couples face in their fertility decisions. However, the theoretical prediction
about the sign of the eect of PMTCT on fertility is unclear. PMTCT may increase fertility
because decreasing the probability that a child is born HIV positive means that the child will
require fewer health inputs while alive and is likely to be more productive. Conversely, PMTCT
may decrease fertility because it increases the expected return to household investment in children's
human capital, which in turn likely causes households to substitute child quality for quantity. Aside
from the eects on the shadow prices of child quantity and child quality, PMTCT may decrease
fertility by reducing the need for replacement and precautionary fertility.
In addition to the sign of the theoretical prediction being ambiguous, there is little reliable
empirical evidence on this question. There are several economic analyses of the eects of the
spread of HIV/AIDS on fertility, human capital investment, and economic growth (e.g., Young
2005, Young 2007, Ahuja et al 2008, Fink and Linnemayr 2009, Fortson 2009, Juhn et al 2009,
Fortson 2010, Kalemli-Ozcan and Turan 2010, Kalemli-Ozcan 2010), but it is far from obvious
that PMTCT should simply reverse many of these eects. One major dierence between the rise
of HIV/AIDS and the introduction of PMTCT is that the HIV/AIDS pandemic aects child and
adult mortality (and life expectancy), whereas PMTCT only directly aects child mortality.2
1The Zambian experience roughly parallels estimates of the broader scale-up in the developing world. For example,
in 2005, just 15 percent of HIV positive pregnant women received PMTCT, whereas 45 percent received PMTCT in
2008, and 53 percent received PMTCT in 2010 (WHO 2010a).
2PMTCT may indirectly aect adult mortality. In a high maternal mortality environment, changes in pregnancy
rates induced by PMTCT availability should aect adult female mortality. Similarly, in a high HIV prevalence
environment, changes in pregnancy-seeking behavior (i.e., unprotected sex) induced by PMTCT availability should
aect adult mortality.
1The rapid expansion of PMTCT in Zambia provides quasi-experimental evidence on the eect
of PMTCT on fertility. I augment the Japanese International Cooperation Agency 2006 Health
Facilities Census, which includes the GPS coordinates of each health facility in Zambia, with newly
assembled data on the month and year each facility began oering PMTCT. Data on reproduc-
tive behavior and fertility outcomes come from repeated nationally representative cross-sectional
household surveys conducted before, during, and after the scale-up, where each survey year includes
respondents from multiple interview months. Combined with detailed geographic information on
the location of survey households, I use these data to measure how reproductive behavior changes
when PMTCT is introduced at a local health clinic. Multiple rounds of survey data before the
introduction of PMTCT, as well as multiple rounds after the introduction PMTCT, mean that I
am able to identify the eect of PMTCT on fertility while controlling for unobserved time-invariant
characteristics of locations receiving PMTCT and dierential trends between PMTCT and non-
PMTCT locations.
I nd evidence that the local introduction of PMTCT reduced pregnancy rates. Although the
estimated average eect is not robust to the full set of controls, my point estimates suggest that
local PMTCT availability reduced pregnancy rates by roughly 3 percentage points, or 10 percent
relative to the mean pregnancy rate. An analysis of the the heterogenous eects of PMTCT
availability indicates that the fertility reduction was concentrated among women who were more
likely to be HIV positive, among women in their main childbearing years, and among women who
had completed secondary school. I also nd that local PMTCT availability increased breastfeeding
rates, an important input into child quality, by roughly 15 percentage points.3 An event study
analysis suggests the absence of a pre-local introduction \eect" and that the medium term response
to local PMTCT introduction was larger than the short term response.
In further support of a causal interpretation of these results, I nd that the local introduction
of PMTCT substantially increased awareness of PMTCT and reduced under-1 child mortality by
approximately 4 percentage points. Similarly, my child mortality estimates are not far from a
back-of-the-envelope calculation of pediatric HIV/AIDS mortality. According to the 2007 DHS,
HIV prevalence among pregnant women is approximately 14 percent. In the absence of PMTCT, a
mother-to-child transmission (MTCT) probability of between 25-50 percent implies that approxi-
mately 3.5-7 percent of children are born HIV+. Estimates indicate that between 25 and 50 percent
of HIV positive infants in this setting die by age one (Spira et al 1999, Taha et al 1999, Dabis et al
2001, Brahmbhatt et al 2001).
3This is consistent with the predictions of a quantity-quality model, in which a decrease in child quantity should
be associated with an increase in child quality. However, there exist at least two alternative interpretations. First,
the increase in breastfeeding could be a response to the decreased risk of infecting one's child through breastfeeding.
Second, widespread use of lactational amenorrhea as a contraceptive method in the developing world means that
breastfeeding may simply be the mechanism by which women are decreasing pregnancy rates.
2To the best of my knowledge, this paper is the rst economic analysis of the behavioral response
to PMTCT, arguably the single most eective prevention intervention in existence.4 However, this
paper contributes to the literature on fertility responses to changes in child mortality risk (e.g.,
Ben-Porath 1976, Wolpin 1984, Sah 1991, Soares 2005, Hossain et al 2007, Angeles 2010, Lucas
2010). Similarly, the current analysis contributes to a broader economic literature on the behavioral
responses to changes in reproductive technology (e.g., Donohue and Levitt 2001, Pop-Eleches 2006,
Portner 2010, Valente 2011).
The paper is organized as follows. Section 2 describes the transmission of HIV from mother-to-
child in Zambia, the medical eects of PMTCT, and the expansion of PMTCT in Zambia. Section
3 provides a conceptual framework for thinking about the behavioral response to PMTCT scale-up.
Section 4 describes the household survey and health facilities census data. Section 5 explains the
empirical strategy I use to identify the fertility response to PMTCT scale-up. Section 6 presents
the results. Section 7 concludes.
2 Prevention of mother-to-child transmission
2.1 MTCT and PMTCT clinical facts
Mother-to-child transmission (MTCT) of HIV is one of the primary sources of new HIV infections.
Approximately 10 percent of new HIV infections are due to MTCT (De Cock et al 2000). During
the rst decade of the twenty-rst century, there were roughly 400,000 to 500,000 new perinatal and
infant HIV infections each year (UNAIDS 2010). The vast majority of mother-to-child transmission
is in Sub-Saharan Africa. More than 90 percent of pediatric HIV infections and 94 percent of
pediatric AIDS deaths occur in this region (Foster and Williamson 2000).
Among pregnant women who are HIV positive, the likelihood of transmission of HIV in the
absence of PMTCT is quite high. There are three ways in which a HIV positive woman may transmit
the virus to her child: in utero, during childbirth, and through breastfeeding. The cumulative
probability of transmission in the absence of PMTCT is between 25 and 45 percent (Dabis and
Ekpini 2002).
Children who acquire HIV from their mother are very likely to die before reaching age ve.5
4Theoretically, abstaining from sexual activity may be as or more eective. However, aside from small population
sub-groups, individuals appear to be highly unlikely to abstain from sexual activity for the entire course of their lives.
5Mother-to-child transmission of HIV is not the only way in which having a HIV positive mother increases the
probability of child death. Maternal mortality due to HIV/AIDS further reduces the resources available to poor
households in poor countries. Consistent with this burden, in a longitudinal study in Rakai, Uganda, Brahmbhatt
et al (2003) nd under-2 child mortality rates of 166 per 1000 for HIV negative children of HIV positive mothers,
compared to 128 per 1000 for HIV negative children of HIV negative mothers. However, mother-to-child transmission
appears to be the largest eect, with a under-2 child mortality rate of 547 per 1000 for HIV positive children of HIV
positive mothers.
3Between 25 and 50 percent of HIV positive infants die by age 1. Similarly, between 35 and 60
percent of HIV positive infants die by age 2 (Spira et al 1999, Taha et al 1999, Dabis et al 2001,
Brahmbhatt et al 2001).6
Prevention of mother-to-child transmission (PTMCT) interventions consist of giving women
and infants antiretrovirals (ARVs) similar to those provided to HIV positive adults. World Health
Organization (WHO) guidelines recommend azidothymidine (AZT) as part of a multiple-drug com-
bination therapy (including nevirapine (NVP)) for mothers and infants (WHO 2006). Meta-analyses
indicate that PMTCT reduces the cumulative probability of transmission from as much as 45 per-
cent in the absence of PMTCT to as little as 3 percent (Dabis and Ekpini 2002, Canning 2006).
Implementation in Zambia appears to dier somewhat, most likely because of resource con-
straints.7 Stringer et al (2003) and Stringer et al (2005) report that standard practice in the
capital district, Lusaka, is to provide a dose of NVP to pregnant woman at time of diagnosis of
being HIV positive, another dose with instruction to take at onset of labor, and a third dose (i.e.,
NVP syrup) to the infant prior to release from a health facility or to be administered by the mother
at home if the birth is not at a health facility. This approach is roughly similar to that in much of
the of the developing world: among HIV positive pregnant women receiving PMTCT in low- and
middle-income countries in 2007, 49 percent received \single-dose" NVP (WHO 2010a).8
2.2 PMTCT scale-up
As part of The United States President's Emergency Plan for AIDS Relief (PEPFAR) and in
conjunction with the Global Fund to Fight AIDS, Tuberculosis, and Malaria and other partners,
access to PMTCT expanded across much of Sub-Saharan Africa during the past decade. For
example, 15 percent of HIV positive pregnant women in Sub-Saharan received PMTCT in 2005,
whereas 45 percent received PMTCT in 2008, and 54 percent received PMTCT in 2010 (WHO
2010a).
Zambia, a PEPAR focus country, has been a major participant in this expansion. As shown in
Figure 1, between the start of 2000 and the end of 2007, the number of health facilities in Zambia
oering PMTCT increased from fewer than 6 to nearly 600.9 Not only was this a large increase in
absolute terms, but the facilities coverage rate increased substantially as well. At the end of this
6Even in the absence of acquiring HIV/AIDS, child mortality in Zambia is high. Overall, the neonatal mortality
rate in Zambia is 36 per 1,000 live births, the under-1 infant mortality rate is 92 per 1,000 live births, and the under-5
child mortality rate is 148 per 1,000 live births. HIV/AIDS accounts for 12% of under-5 mortality in Zambia (WHO
2010b).
7Consistent with this explanation, Skordis and Nattrass (2002) show that single-dose nevirapine for mother and
child is more cost-eective than using a longer regimen of zidovudine (i.e., AZT).
8\Single-dose" means a single drug, instead of a combination therapy (i.e., \ARV cocktail"). The three-stage NVP
treatment in Zambia is \single-dose".
9The data used to create Figures 1 and 2 are discussed in more detail in Section 4.
4period, approximately 40 percent of health facilities in Zambia oered PMTCT.
PMTCT expansion was not distributed evenly across Zambia. Figure 2 shows the expansion of
PMTCT in Zambia by year of introduction, as well as the district-level population density and the
main transportation routes. The initial round of PMTCT expansion was concentrated in the three
largest urban areas in Zambia (Lusaka, Kitwe, and Ndola), as well as in urban and peri-urban areas
in Southern Province. Subsequent rounds of expansion continued in these areas, in other urban
areas, and in rural areas along the main road network.
The vast majority of pregnant women in Zambia visit an antenatal clinic at least once dur-
ing their pregnancy, helping ensure that the scale-up of access to PMTCT translated into use of
PMTCT.10 Among the respondents in the nationally representative survey data used in the cur-
rent analysis, more than 93 percent of women who report being pregnant at any point during the
twelve months prior to the survey date reported at least one visit to an antenatal clinic during
that pregnancy. Perhaps surprisingly, this probability is remarkably 
at across the survey rounds,
varying no more than two percentage points between any two years among the four survey rounds
(i.e., 2001, 2003, 2005, and 2007). Similarly, the likelihood of visiting an antenatal clinic at least
once during pregnancy is greater than 90 percent in urban areas and greater than 90 percent in
rural areas. As of 2007, the modal visit to an antenatal clinic occurred during the fourth to fth
month of pregnancy (Central Statistical Oce et al 2009).
Although most pregnant women visit an antenatal clinic, there are two additional possible
constraints to ensuring eective PMTCT coverage. First, most births occur at home and not in a
health facility. For example, in the 2007 Demographic Health Survey (DHS), 52 percent of births
during the ve years proceeding the survey date occurred in the home (Central Statistical Oce et
al 2009). However, nevirapine (NVP) is provided to pregnant women upon diagnosis to be taken
at home at the onset of labor and during the rst few weeks of breastfeeding (Stringer et al 2003,
Stringer et al 2005). Thus, home births do not appear to be a major constraint unless adherence
is low among pregnant women conditional on receiving the NVP to be taken at home.
Second, evidence from Goldstein et al (2010) on the eect of health worker absence on HIV/AIDS-
related antenatal care in a clinic in Kenya suggests that health worker absence may be an important
constraint in Zambia. Although there do not appear to be data on health worker absence in Zam-
bia antenatal clinics, there is nationally representative information on HIV testing during antenatal
clinic visits. Among female respondents in the 2003 Zambia Sexual Behavior Survey (ZSBS) re-
10PEPFAR (http://www.pepfar.gov/countries/zambia/index.htm) reports that 66,400 HIV-positive pregnant
women received PMTCT through PEPFAR funding during 2010. With a population of approximately 12 million
individuals, half of whom are between the ages of 15 and 49, and a further subset of 50 percent are women, there are
roughly 3 million women of childbearing age. With a pregnancy rate of approximately 0.31 and HIV prevalence of
14 percent among pregnant women, this indicates an individual-level PMTCT coverage rate through PEPFAR of ap-
proximately 5 percent. The existence of non-PEPFAR funded PMTCT programs means that the total individual-level
PMTCT coverage rate is above 5 percent.
5porting an antenatal clinic visit during a pregnancy in the twelve months proceeding the survey
date, 15 percent report being oered a HIV test during the visit and 45 percent of these report ac-
cepting the HIV test. By the 2005 ZSBS, these gures had increased to 27 percent and 60 percent,
respectively. In the 2007 Demographic Health Survey (DHS), 64 percent of women received a HIV
test during an antenatal clinic.
The rapid increase in the proportion of women receiving a HIV test at an antenatal clinic
visit, combined with the relatively high acceptance rate, indicates that the physical expansion of
PMTCT generated a large increase in eective coverage of HIV positive pregnant women and at-
risk infants. UNICEF (2010) reports that 20 percent of HIV positive pregnant women in Zambia
received PMTCT in 2004 and 8 percent of infants born to HIV positive women received PMTCT
at birth. By 2007, these proportions had increased to 52 percent and 23 percent, respectively. An
individual coverage rate that is higher than the facilities coverage rate is consistent with the higher
population densities in the locations that were more likely to receive PMTCT (i.e., urban areas).
During this period, Zambia also dramatically expanded access to antiretroviral therapy (ART)
for adults and to voluntary counseling and testing (VCT).11 Table 1 shows the hierarchy of
HIV/AIDS service expansion. Relative costs appear to be a major determinant of the hierarchy
of expansion. VCT expansion slightly outpaced PMTCT expansion and ART expansion expan-
sion lagged well behind PMTCT. For example, by the end of 2007, approximately 47 percent, 42
percent, and 21 percent of health facilities oered VCT, PMTCT, and ART, respectively. Among




Prevention of mother-to-child transmission (PMTCT) interventions reduce the likelihood of a HIV
positive woman transmitting HIV in utero, during childbirth, or to her child through breastfeeding.
PMTCT reduces the cumulative probability from between 25-45 percent in the absence of PMTCT
to as little as 3 percent (Dabis and Ekpini 2002, Canning 2006). Between 25 and 50 percent of
HIV positive children die by age 1 and between 35 to 60 percent of HIV positive children die by
age 2 (Spira et al 1999, Taha et al 1999, Dabis et al 2001, Brahmbhatt et al 2001). Thus, PMTCT
should increase life expectancy at birth for children born to HIV positive mothers, conditional on
fertility seeking behavior and child human capital investment behavior remaining unchanged.
11Although access to the three main HIV/AIDS services increased rapidly during this period, access to and/or
the quality of non-HIV/AIDS related care may have decreased. Case and Paxson (2011) show that the rise of the
HIV/AIDS pandemic led to a decline in the quality of general health care in Sub-Saharan Africa.
6A simple quantity-quality model of fertility and household investment in children's human
capital (Becker and Lewis 1976) generates an ambiguous prediction about the net eect of PMTCT
on fertility. The decrease in child mortality caused by PMTCT reduces the cost of child quantity.
That is, PMTCT reduces the number of births the household requires to achieve a given number
of surviving children. Thus, PMTCT reduces the price of child quantity, leading to an increase in
fertility.
Conversely, PMTCT means that infants are more likely to live on to older ages. This increases
the expected return to household investments in child quality, or in other words, reduces the price
of child quality. This should lead to an increase in the quality of children and, under the quantity-
quality tradeo in this model, reduce the quantity of children, leading to a decrease in fertility.
Not only does PMTCT change the shadow prices of child quantity and child quality, but PMTCT
also reduces the need for replacement fertility. Because PMTCT reduces child mortality, PMTCT
will reduce fertility because the household will need to \replace" fewer births (i.e., births that result
in child death).12 Thus, even holding the shadow prices of child quantity and child quality constant,
we would still expect PMTCT to aect fertility.
In addition to reducing the likelihood of mother-to-child transmission, receiving PMTCT may
provide information to pregnant women about their HIV status. To receive PMTCT, a pregnant
woman must test HIV positive. After receiving the result of this test, she may revise her belief
about her HIV status. Although evidence on the behavioral response to learning one's HIV status
is mixed, the change in her beliefs may change her subsequent reproductive decisions.
3.2 Timing
To understand the timing of the fertility response to the local introduction of PMTCT, consider
the following timeline. Let t denote the month at which a woman is surveyed about her pregnancy
status during the twelve months leading up to the interview date, inclusive. For women who report
being pregnant at some point between t and t 11, the likely range of possible conception dates is
t 1 to t 20. Assuming individuals are perfectly informed about local PMTCT availability on the
date that it is introduced, the local introduction of PTMCT by period t   2 or before may aect
12Doepke (2005) examines \replacement fertility" (i.e., a mechanism where households increase fertility ex post
in response to child mortality when birth choice is sequential) and \hoarding" (or precautionary fertility) (i.e., a
mechanism where households increase fertility ex ante in response to expected child mortality). Doepke (2005)
demonstrates that because households may accidentally have \too many" children if realized child mortality is low,
replacement fertility dominates precautionary fertility as a fertility strategy in the face of child mortality. In contrast,
Ben-Porath (1976) notes that hoarding (or precautionary fertility) may be important if there exists substantial risk of
child mortality after a woman's childbearing years are over (e.g., if children are likely to die as adults). Because HIV
positive infants die with high probability within two years, whereas mortality rates among adults who acquire HIV
do not begin to rise until 8-10 years after the infection date, the main risk of child mortality appears to be during
the woman's childbearing years.
7fertility behavior as measured at period t.
If conceptions are evenly distributed across months, then the representative pregnancy mea-
sured during the interval t to t   11 would have begun in approximately period t   10. That is,
the representative pregnancy would have been conceived midway through the possible conception
interval, t   1 to t   20. Assuming individuals are not changing their fertility behavior in antici-
pation of the local introduction of PMTCT, this suggests that we are unlikely to see an eect of
local PMTCT availability on pregnancy rates that are measured during the interval t to t 11 until
PMTCT has been locally available for approximately 11 months.
The lag between local PMTCT introduction and the fertility response may be even greater than
this. PMTCT may aect fertility not just through decreased risk of death of future births, but
also through decreased mortality among recent births. Under this latter mechanism, a decrease in
pregnancy, either through lactational amenorrhea due to breastfeeding a child who is still alive or
through a decrease in replacement fertility, would take longer to appear.
4 Data
4.1 Individual-level data
Data on fertility come from the 2001 and 2007 Zambia Demographic Health Surveys (DHS) and
the 2003 and 2005 Zambia Sexual Behavior Surveys (ZSBS). These are repeated cross-sectional
nationally representative household surveys. Administrative records on the primary sampling units
in these surveys allows me to calculate the approximate latitude and longitude of each survey
household.13 This process yields 7,683 adult females (i.e., ages 15-49) in the 2001 DHS, 2,296 adult
females in the 2003 ZSBS, 2,072 adult females in the 2005 ZBS, and 7,146 adult females in the 2007
DHS.14
13The nature of the spatial information in these surveys likely introduces bias toward zero in the estimates of the
fertility response to local PMTCT availability. For the ZSBS and the 2001 DHS, I use information on the respondent's
Standard Enumeration Area (SEA) of residence to dene the precise location of the respondent as the centroid of this
SEA. These administrative units were designed to capture approximately 1,000 individuals, so although they tend to
be quite small in urban areas they may be relatively large in rural areas. The 2007 DHS contains slightly dierent
spatial information. Instead of revealing the respondent's SEA of residence, the 2007 DHS provides GPS data points
that are intentionally measured with error for each respondent to address privacy concerns associated with the HIV
testing module in this DHS. In the Zambia 2007 DHS, these data points were generated by adding a random vector
with length drawn from a uniform distribution on 0 to 10 kilometers to the latitude and longitude of the centroid of
the SEA of residence.
14The digitized census map provided by the Zambia Central Statistical Oce, which I use to identify the location
of the primary sampling units for the respondents in the 2001-2005 survey rounds, is missing approximately seven
percent of the Statistical Enumeration Areas (SEAs) in Zambia. Thus, I am unable to identify the precise location of
approximately seven percent of the 2001-2005 survey respondents and exclude these respondents from the empirical
analysis.
8The main fertility measure I use in this analysis is an indicator variable for whether the female
respondent reported being pregnant in the twelve months leading up to the survey date. I also use
three measures of child mortality: neonatal (i.e., one month or younger) mortality, under-1 (i.e., 12
months or younger) mortality, and under-2 (i.e., 24 months or younger) mortality. Mortality data
come from the birth history module in the DHS and provide retrospective data on child mortality.
To augment the fertility and mortality outcomes, I examine knowledge about the existence of
PMTCT and I examine breastfeeding behavior among women with children age 24 months or
younger.
Table 2 reports the age proles among the DHS and ZSBS respondents for several of the
key variables in this analysis. Several important facts emerge from this analysis. First, the main
childbearing ages in Zambia are ages 20-29 and, to a slightly lesser extent, ages 30-39. Second, as in
most high HIV prevalence countries, the HIV prevalence-age prole takes an inverted U-shape and
peaks among ages 30-39. Third, under-1 mortality, knowledge about mother-to-child transmission
(MTCT), and knowledge about PMTCT remain relatively 
at across age groups, although the
youngest women are somewhat less informed than women at older ages.
Table 2 also illustrates how these key variables vary by the education level of the respondents.
More educated women have fewer children and their children are less likely to die by age 1, despite
the fact that more educated women are more likely to be HIV positive. Perhaps not surprisingly,
more educated women are more likely to know about mother-to-child transmission and (MTCT)
and about PMTCT. They are also less likely to breastfeed their children, possibly because they are
more aware of the increased risk HIV transmission. However, more educated women may also have
a higher time cost of breastfeeding and have better access to nutritional inputs for their children
outside of breastfeeding.
In Table 3, I provide mean characteristics of respondents residing in locations that ever received
PMTCT and in locations that never received PMTCT. Partly because of the non-random placement
of PMTCT sites, respondents in locations receiving PMTCT appear to be more educated, less likely
to be married, and more likely to be HIV positive. They also have lower levels of fertility and greater
knowledge about PMTCT.
4.2 Health facilities data
I collected retrospective data on the month and year each health facility began oering each of the
three main HIV/AIDS services: PMTCT, antiretroviral therapy (ART), and voluntary counseling
and testing (VCT). The 2006 Japanese International Cooperation Agency (JICA) Health Facility
Census (HFC) surveyed each health clinic and hospital in Zambia and recorded the exact latitude
and longitude of each health site. To augment these data, I arranged for each clinic to be re-
surveyed to provide information on the month and year (if any) it began oering each of the three
9main HIV/AIDS services. This process eectively began in June of 2008 so this retrospective panel
provides comprehensive information on the expansion of HIV/AIDS services in Zambia through
the middle of 2008.15
5 Empirical strategy
The main empirical strategy in this paper is to measure the change in fertility associated with the
local introduction of PMTCT while controlling for a host of time and geographic xed eects and
linear trends. To implement this strategy, I use the detailed spatial information in the JICA 2006
HFC and the household survey data to calculate the distance from each survey respondent to each
health facility and measure fertility among respondents who reside near health facilities currently
oering PMTCT. Because I have information on fertility in locations receiving PMTCT before they
received PMTCT, I am able to control for unobservable characteristics (both time-invariant and
time-varying) aecting fertility that are associated with the placement of PMTCT sites. PMTCT
was not introduced everywhere simultaneously, so instead of including a \post" indicator as in a
standard dierence-in-dierences specication I include year xed eects interacted with month
xed eects. This controls for unobserved time-specic shocks to fertility. I also include district
xed eects to control for additional time-invariant spatial heterogeneity.16
Thus, the primary regression equation is:
fertilityijt = 1PMTCTij(t 11) + 2PMTCTeverij + X
0
ijt  + j + t + ijt (1)
where fertilityijt denotes the reproductive behavior of female respondent i residing in district
j in month t (e.g., January 2007), PMTCTij(t 11) is an indicator variable equal to one if a health
clinic oering PMTCT at least 11 months prior to the survey date is located near respondent i,
PMTCTeverij is an indicator variable equal to one if a health clinic located near respondent i
ever oered PMTCT even if it was subsequent to the interview date for respondent i, Xijt is a
vector of individual-level demographic controls, j are district xed eects, and t are month times
year xed eects. As in a standard dierence-in-dierences empirical strategy, I interpret 1 as the
causal eect of local PMTCT availability on fertility.17
15Service interruptions (e.g., because of ARV shortages or health worker absence) mean that PMTCT may not
have been continuously available at all of these clinics from the local introduction date onward. However, this should
only work against the regression analysis yielding any estimate eect of local PMTCT availability on pregnancy rates.
The fact that I nd a large and statistically signicant eect suggests that the behavioral response to any service
interruptions was not large enough to outweigh the eect of the documented service availability.
16This is a concern because I don't observe fertility before and after local PMTCT introduction in every location
where I have household survey respondents. There are 72 districts in Zambia and the major urban areas are often
their own district.
17In a dierence-in-dierences interpretation of this regression specication, PMTCTijt is \treatment" interacted
10There remain at least two major threats to identifying the causal eect of local PMTCT avail-
ability on fertility. First, PMTCT may have been introduced in locations that were following a
dierent time trend than those locations that did not receive PMTCT.18 To address this concern,
in the majority of specications I include district-specic linear time trends and a linear time trend
for locations ever receiving PMTCT. Second, the expansion of ART and VCT may have been cor-
related with the expansion of PMTCT. Thus, in the majority of specications I use information
from the augmented-HFC to control for proximity to ART and VCT.19
I measure fertility using an indicator variable equal to one if the respondent reported being
pregnant at some point during the twelve months prior to the survey month, inclusive. The rep-
resentative location with PMTCT in Zambia received it around 2005. Birth spacing in Zambia is
roughly 3 to 4 years. Thus, the representative woman exposed to PMTCT in Zambia only faced
one (or fewer) likely births after the local introduction of PMTCT. Because very few women were
at risk of having more than one birth during this period, I focus on pregnancy rates as my primary
measure of fertility behavior.
The baseline specication denes a respondent as being near a health clinic if the respondent
lives within 10 kilometers of the nearest health clinic. In an analysis of the correlates of maternal
health care usage in Kalabo District in Zambia, Stekelenburg et al (2004) nd that usage rates
decline substantially for women residing more than a two-hour walk (i.e., roughly 10 kilometers)
from a maternal health care site. Similarly, female respondents in the 2007 DHS indicate that
distance is one of the primary barriers to seeking health care (Central Statistical Oce et al 2009).
6 Results
6.1 Eect of local PMTCT on fertility
The regression results suggest that the local introduction of PMTCT reduced pregnancy rates.
Estimates of the eect of local PMTCT availability on pregnancy rates appear in Table 4. All
specications include district xed eects and month times year xed eects. In addition, all
specications include an indicator variable equal to one if a clinic within 10 kilometers of the
respondent ever oered PMTCT. Standard errors are clustered by Standard Enumeration Area
(SEA).
Column (1) presents the results from the baseline specication. The point estimate indicates
with \post", PMTCTeverij is the \treatment" indicator variable, and the month xed eects interacted with the
year xed eects correspond to the standard \post" variable.
18The rural-urban dierence in fertility trends during the period spanned by the household survey data support
this hypothesis. Between 2001 and 2007, rural fertility increased from 6.9 births per woman to 7.5 births per woman,
whereas urban fertility remained constant at 4.3 births per woman (Central Statistical Oce et al 2009).
19In the specications in which I control for ART and VCT availability, I include the ART (and VCT) analogues
of PMTCTijt and PMTCTeverij.
11that local PMTCT availability (i.e., at a clinic located within 10 kilometers of the respondent)
reduced the likelihood that the respondent was pregnant by 4.6 percentage points. This eect is
fairly large not only in absolute terms, but also in relative terms and is statistically signicant at the
1 percent level. Compared to the mean pregnant rate of 0.31 in the entire sample, a 4.6 percentage
point reduction corresponds to approximately a 15 percent reduction in pregnancy rates.20
In Column (2), I include district-specic linear time trends and a linear time trend for locations
ever receiving PMTCT. This should address concerns that PMTCT locations and non-PMTCT
locations may have been on dierent time trends prior to the local introduction of PMTCT. Al-
though including these controls attenuates the coecient estimate somewhat, it remains relatively
large and statistically signicant at the 5 percent level.
The coecient estimate presented in Column (3) comes from a regression where I control for
the availability of the two other main HIV/AIDS (i.e., voluntary counseling and testing (VCT) and
antiretroviral therapy for adults (ART)). To do so, for each service I include an indicator variable
equal to one if a clinic within 10 kilometers ever oered that service and an indicator variable equal
to one if a clinic within 10 kilometers of the respondent oered that service at least eleven months
prior to the respondent's interview date. The point estimate in Column (3) is somewhat smaller
than that in the baseline specication and is statistically signicant at the 10 percent level.
Finally, Column (4) reports the results from a regression that simultaneously includes the linear
trends and the controls for the availability of the other main HIV/AIDS services. Using the full
set of controls yields a point estimate that is roughly three-quarters the magnitude of the baseline
estimate and is no longer statistically signicant at conventional levels. In the regressions that
follow, I include both sets of controls (i.e., the linear trend controls and the indicator variables for
ART (and for VCT) ever available within 10 kilometers and for ART (and for VCT) available at
least eleven months prior to the respondent's interview date).
6.2 Eect dynamics
The longitudinal dimension of these data enables several additional analyses that support a causal
interpretation of the baseline results. Figure 3 provides an event study analysis of the eect of
local PMTCT availability on pregnancy behavior. This gure plots the estimates of k from the
following regression equation:
20An alternative explanation for the eect of local PMTCT availability on pregnancy is that PMTCT may be
bundled with additional emphasis on family planning services. However, empirical evidence does not support this
hypothesis. The 2001 and 2007 DHS ask respondents whether a health worker discussed family planning with the
respondent during a visit during the twelve months leading up to the survey date. Using the same specication as in
Column (1) of Table 4, regression results indicate that local PMTCT availability does not increase the likelihood a
health worker discussed family planning with the respondent. In fact, the coecient on local PMTCT availability is
negative (i.e., -0.022), although statistically insignicant (i.e., p-value is 0.355). The lack of an eect of local PMTCT
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where ijt denotes the twelve (or eleven) month event window and is dened such that  = 0 for
respondents surveyed 0 to 10 months after the local introduction of PMTCT,  = 1 for respondents
surveyed 11 to 23 months after the local introduction of PMTCT,  = 2 for respondents surveyed
24 to 35 months after the local introduction of PMTCT, and so forth. For  < 0, respondents were
surveyed prior to the local introduction of PMTCT. tj and tPMTCTeverij are the district-specic
trends and the linear trend for locations ever receiving PMTCT, respectively. S
0
ijt is a vector of
controls for the two other main HIV/AIDS services. Aside from the event study parameters, this
specication is identical to the specication with the full set of controls in Table 4 (i.e., Column
(4)).
The coecient estimates plotted in Figure 3 are consistent with a causal interpretation of the
baseline results.21 There is no evidence of a pre-local introduction trend in fertility in locations
ultimately receiving PMTCT. Furthermore, there is evidence of a clear downward trend in the
point estimates that begins with the local introduction of PMTCT.
Table 5 continues this dynamic analysis by expanding the specication with the full set of
controls in Table 4 (i.e., Column (4)) to allow the eect of local PMTCT availability to vary
by the length of time it has been available. In particular, I allow for an additional eect of
PMTCT on fertility in locations in which PMTCT has been available for at least thirty-six months.
The coecient estimates suggest that although fertility may respond in the short term, it is only
after PMTCT has been available for at least thirty-six months that respondents demonstrate a
statistically signicant reduction in the likelihood of pregnancy. Moreover, the point estimates
suggest that the medium term response is approximately twice as large as the short term response.
This nding is consistent with a reduction in replacement fertility, a mechanism that would
generate a lagged response. However, the lagged response is also consistent with another channel
by which PMTCT may aect fertility: lactational amenorrhea due to breastfeeding a child who is
still alive. More generally, if social learning about PMTCT availability is important, then we might
expect a larger response in the medium term than in the short term.
21This specication includes respondents in locations that never received PMTCT. A Wald test fails to reject the
equality of the event study coecients across this sample specication and a restricted sample specication which
includes only those respondents in locations that received PMTCT by the end of the augmented HFC.
136.3 Heterogeneity by HIV prevalence
Presumably, women who are more likely to be HIV positive should demonstrate a greater fertility
response to the local availability of PMTCT. Because the 2007 DHS is the only survey round that
includes information on HIV status that is linked to information on fertility decisions, I cannot
examine how the response varies by the respondents' actual HIV status. However, I can examine
how it varies by HIV prevalence across demographic group as dened by the interaction of gender,
ve-year age group, and province of residence.22
Table 6 presents the results of a regression that allows the fertility response to vary by HIV
prevalence among the respondent's demographic group. In particular, I examine whether women
in demographic groups with HIV prevalence above the median level responded more strongly to
the local availability of PMTCT. The results presented in Table 6 indicate that women who were
more likely to be HIV positive reduced their fertility more in response to PMTCT availability.
Respondents in demographic groups with HIV prevalence above the median level reduced their
likelihood of being pregnant by 4.4 percentage points, an eect that is signicant at the 10 percent
level. In contrast, women in demographic groups with HIV prevalence below the median level did
not demonstrate a statistically signicant change in their pregnancy rate.
6.4 Heterogeneity by age
There are several reasons to think that women of dierent ages may have responded dierently
to the introduction of PMTCT. As shown in Table 2, fertility behavior varies substantially across
age groups. Older women may be close to having completed their childbearing and hence may be
unlikely to change their fertility behavior in response to the introduction of PMTCT. Similarly, older
women may be less informed about recent developments in reproductive technology. Conversely,
younger women are less likely to have ever had a child, less likely to have had a child die, and hence
less likely to be at risk of engaging in replacement fertility.
To examine this question, I allow the eect of local PMTCT to vary by the age of the respondent.
Table 7 presents the results from this regression. The omitted age category is age 15-19. The
coecient estimates suggest that the reduction in pregnancy rates was concentrated among women
in their main childbearing years. Specically, local PMTCT availability reduced pregnancy rates
among women age 20-29 by approximately 4 percentage points (signicant at the 5 percent level)
and did not signicantly reduce pregnancy rates among women in other age groups.
22There is substantial variation in HIV prevalence across age groups and provinces. For example, as shown in
Table 2, HIV prevalence is approximately four times as high among women age 30-34 and 35-39 than among women
age 15-19. Similarly, HIV prevalence in Lusaka Province is nearly three times as high as in Northern Province. In
addition, aggregate HIV prevalence in Zambia has been relatively 
at during the period 2001-07 (Central Statistical
Oce et al 2009).
14Although this evidence may confound age and cohort eects, it appears that the local availability
of PMTCT did not reduce fertility behavior by the same amount across the life cycle. Instead,
it appears that the response was larger in the main childbearing years. One explanation for this
nding is that these are the women who were most likely to have recently avoided transmission from
mother-to-child because of the availability of PMTCT and hence had a lower need for replacement
fertility. Another explanation is that these are the women who are most likely to have knowledge of
PMTCT (see Table 2). However, women in the main childbearing years may have greater knowledge
of PMTCT because they are more likely to be pregnant and hence may be more likely to have been
exposed to PMTCT during an antenatal visit.
6.5 Heterogeneity by education
Table 8 explores whether the response to local PMTCT availability varied by education level. To do
so, I interact the measure of PMTCT availability with indicator variables for completed primary
schooling and for completed secondary schooling. The results indicate that women who have
completed secondary school responded much more than did women with lower levels of schooling.
The point estimates indicate that local PMTCT availability had no eect on pregnancy rates among
women with less than secondary school completion. In contrast, local PMTCT availability reduced
pregnancy rates among women who have completed secondary school by 5.2 percentage points, an
eect that is statistically signicant at the 10 percent level.
There are several possible explanations for the larger fertility response among more-educated
women. First, more educated women may be more informed about or have better access to local
PMTCT. The eect of local PMTCT availability on knowledge of PMTCT presented in the next
sub-section is consistent with this interpretation. Second, more educated women may have better
access to eective contraception. Among women with primary school completion or less, fewer
than 38 percent report current contraceptive use (Central Statistical Oce et al 2009). In contrast,
more than 49 percent of women with secondary school completion report current contraceptive use
and more than 57 percent of women with more than secondary school completion report current
contraceptive use.
A third possible reason is that observed fertility among less educated women may be at a tech-
nological constraint, possibly because their optimal number of births is at or above a technological
constraint rather than because of some unmet desire for contraception.23 The rise of HIV/AIDS
may not have aected their fertility (Fortson 2009) and the reduction in child mortality due to
PMTCT may not either. Although it is dicult to determine whether less educated women in this
setting truly are at a technological fertility constraint, fertility rates in this group are quite high
on average. Among women without primary school completion in Zambia, the total fertility rate
23The biological maximum for fertility is one factor possibly determining a technological fertility constraint.
15(TFR) is 8.2 (Central Statistical Oce et al 2009).24
6.6 Eect of local PMTCT on knowledge of PMTCT
In addition to increasing access to PMTCT, local PMTCT availability may aect fertility behavior
because it increases knowledge about PMTCT. The current analysis does not attempt to disag-
gregate the total eect of PMTCT on fertility decisions into these two eects (i.e., a price eect
and a health information eect). Nonetheless, examining the eect of local PMTCT availability
on knowledge about PMTCT provides complementary evidence on the main results presented thus
far.
The rst two columns of Table 9 investigate whether local PMTCT availability increased aware-
ness of PMTCT and whether the awareness eect varied by the education level of the respondent.
As shown in Table 2, more than 90 percent of female respondents know of mother-to-child trans-
mission (MTCT). However, fewer than half of female respondents know of PMTCT.25
Local PMTCT availability appears to aect knowledge about PMTCT. The estimated eect
presented in Column (1) of Table 9 indicates that local PMTCT availability increased the likelihood
that a woman knows that it is possible to prevent mother-to-child transmission by 4.8 percentage
points, an eect that is statistically signicant at the 1 percent level. Column (2) allows the eect to
vary by education level of the respondent. The results presented in Column (2) indicate that there
was not a statistically signicant eect for women who had less than secondary school completion
and that there was a 10.2 percentage point increase among women who had completed secondary
school (signicant at the 1 percent level).
6.7 Eect of local PMTCT on breastfeeding
Avoiding breastfeeding reduces the probability of mother-to-child transmission (MTCT) by roughly
15-20 percentage points (Newell et al 2004). However, breastfeeding is an important nutritional
input for infants, particularly in resource-constrained settings. Thus, current World Health Orga-
nization (WHO) guidelines recommend breastfeeding for women who have unknown HIV status
and even for women who are known to be HIV positive (WHO 2009).
The next two columns in Table 9 explore the eect of local PMTCT availability on breastfeeding
and whether the breastfeeding eect varied by the education level of the respondent. These regres-
24Bongaarts (1978) provides estimates of several measures of the biological fertility constraint. A TFR of 8.2
is within the range of estimates of the biological constraint after taking into account lactational infecundity (i.e.,
the \total natural marital fertility rate"). For high fertility countries (i.e., countries with a high rate of lactational
infecundity due to repeated and lengthy breastfeeding spells), these estimates range from 7.0 and 11.0. The pure
biological maximum (i.e., the \total fecundity rate") is between 13.0 and 17.5.
25The 2001 DHS does not ask respondents about knowledge of PMTCT, presumably because it was not yet readily
available in Zambia. Because only 3 percent of respondents in 2003 reported knowledge of PMTCT, I treat knowledge
of PMTCT in 2001 as zero.
16sions use the child age 0-24 months as the unit of observation instead of the mother and restrict the
sample of children to those born January 1999 or later.26 The coecient estimate in Column (3)
indicates that local PMTCT availability increased the probability of breastfeeding for a child age
24 months or younger by approximately 17 percentage points, an eect that is signicant at the 1
percent level.27 The positive eect of local PMTCT availability on the likelihood of breastfeeding
is consistent with the prophylactic eect of PMTCT dominating the information eect of PMTCT.
That is, although local PMTCT availability may increase a pregnant woman's awareness of being
HIV positive, receiving PMTCT reduces the risk of transmission associated with breastfeeding. As
presented in Column (4), allowing the eect of PMTCT on breastfeeding to vary by the education
level of the mother does not suggest that the eect was greater among more educated women.
6.8 Eect of local PMTCT on child mortality
The dramatic increase in PMTCT availability suggests we should observe a concurrent reduction
in child mortality. Table 10 examines the eect of local PMTCT availability on neonatal mortality,
under-1 child mortality, and under-2 child mortality. As with the breastfeeding regressions, these
regressions use the child as the unit of observation instead of the mother and restrict the sample
of children to those born January 1999 or later. The dependent variable in Columns (1), (2), and
(3) is an indicator equal to one if the child died by 1 month of age, by 12 months of age, and by 24
months of age, respectively.
Throughout, the point estimates indicate that the local availability of PMTCT is associated
with lower child mortality rates. For neonatal mortality and under-one year mortality, the local
introduction of PMTCT reduces child mortality rates by between roughly 3 and 4 percentage
points, eects that are statistically signicant at the 1 percent level. Compared to the overall
probabilities of 0.041 and 0.089 of child death by one month and age 1, respectively, the point
estimates correspond to 68 and 45 percent reductions in child mortality rates. The local introduction
of PMTCT is not associated with a statistically signicant reduction in under-2 child mortality
rates. However, the rapid onset of AIDS-related morbidity for infants born HIV positive means
that HIV/AIDS-related mortality likely constitutes a smaller fraction of under-2 child death causes
of death than at younger ages. In any case, the coecient estimate is negative and not dramatically
26The median breastfeeding duration in Zambia is approximately 20 months (Central Statistical Oce et al 2009).
27In an analysis of the eect of health worker absence at a single antenatal clinic in Western Kenya on health
outcomes, Goldstein et al (2010) nd that the presence of a PMTCT nurse when a pregnant woman visits an antenatal
clinic is associated with no change in the probability of receiving PMTCT or in the probability of breastfeeding.
However, among the subset of pregnant women who believe they are HIV positive the presence of a PMTCT nurse
increases the probability they receive PMTCT by 7.4 percentage points and decreases the probability they breastfeed
by 9 percentage points. The seemingly divergent eects documented in Goldstein et al (2010) and in the current
analysis suggest that there is heterogeneity across locations in the advice and care that antenatal clinics provide
clients.
17dierent in magnitude from those in Columns (1) and (2), consistent with a large reduction in child
mortality caused by the local introduction of PMTCT.
7 Conclusion
This paper examines fertility responses to a dramatic change in the availability of a critical re-
productive technology, prevention of mother-to-child transmission of HIV (PMTCT), in one of the
highest HIV prevalence and highest fertility countries in the world. I use three main sets of nation-
ally representative data to estimate the causal eects of this country-wide expansion. First, data
on reproductive behavior and child mortality before and after the local introduction of PMTCT
come from four rounds of repeated cross-sectional nationally representative surveys. Second, the
JICA 2006 Health Facilities Census provides the exact GPS coordinates of each hospital and health
clinic in Zambia. Combined with relatively precise information on the latitude and longitude of
each respondent in the survey data, I am able to calculate the distance from each respondent to
each health facility. Third, I use newly assembled data for each health facility on the month and
year it introduced PMTCT.
The quasi-experimental evidence I present in this paper suggests that PMTCT scale-up in
Zambia generated a reduction in pregnancy rates for respondents residing near health facilities
oering PMTCT. My estimates suggest that local PMTCT availability (i.e., at a clinic within 10
kilometers of a respondent) reduced the likelihood the respondent was pregnant by approximately 3
percentage points (i.e., roughly a 10 percent reduction). Larger estimated responses among women
who were more likely to be HIV positive and in the medium term than in the short term support
a causal interpretation of this estimated eect. Similarly, the estimated eect of local PMTCT
availability on child mortality and a simple epidemiological calculation are consistent with the
estimated fertility response to the local introduction of PMTCT. In addition to these ndings, the
results indicate that local PMTCT availability increased breastfeeding rates among infants (i.e.,
children ages 0-24 months) by more than 15 percentage points, suggesting that PMTCT generated
increased investment in child quality.
These results indicate that the continued expansion of PMTCT in Sub-Saharan Africa may
reduce pregnancy rates, as well as increase investments in child quality at a critical age. Because
women and households likely will spend fewer resources in the pursuit of child quantity, this may
release resources (including female labor) previously allocated to the production of child quantity
for alternative uses. This suggests that PMTCT scale-up is not just a humanitarian success, but
may also promote economic development and growth.
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Figure 3: Event Study Analysis of Effect of Local PMTCT on Fertility 
coefficient estimate 
event time in months Table 1: Hierarchy of HIV/AIDS Service Expansion
number percent number percent number percent
(1) (2) (3) (4) (5) (6)
December 2001:
All health facilities 4 0.3 28 2.0 76 5.4
PMTCT sites 2 7.1 28 100.0 27 96.4
December 2003:
All health facilities 43 3.1 90 6.4 187 13.4
PMTCT sites 35 38.9 90 100.0 84 93.3
December 2005:
All health facilities 166 11.9 372 26.6 513 36.7
PMTCT sites 145 39.0 372 100.0 342 91.9
December 2007:
All health facilities 300 21.4 582 41.6 661 47.2
PMTCT sites 287 49.3 582 100.0 551 94.7
Notes: Reports number and percentage of sites by end of year.
Data come from augmented JICA 2006 HFC.
ART PMTCT VCTTable 2: Mean Characteristics of Female DHS and ZSBS Respondents by Age and Education
number of children HIV under-1 currently
pregnant ever born positive child death know MTCT know PMTCT breastfeeding
(1) (2) (3) (4) (5) (6) (7)
Age
15-19 0.22 0.31 0.06 0.10 0.81 0.26 0.82
20-24 0.42 1.54 0.13 0.09 0.89 0.32 0.79
25-29 0.43 2.87 0.21 0.09 0.92 0.36 0.77
30-34 0.38 4.19 0.25 0.08 0.93 0.37 0.81
35-39 0.29 5.51 0.25 0.09 0.92 0.34 0.81
40-44 0.15 6.48 0.20 0.09 0.91 0.31 0.83
45-49 0.04 6.97 0.14 0.09 0.90 0.32 0.64
Education
Did not complete primary 0.37 3.52 0.13 0.09 0.85 0.27 0.82
Completed primary school 0.27 2.71 0.20 0.08 0.93 0.37 0.78
Completed secondary school 0.24 2.08 0.22 0.07 0.92 0.41 0.67
All females 0.31 3.00 0.17 0.09 0.89 0.33 0.80
Observations 17,391 17,376 5,341 12,868 17,204 16,676 3,628
Notes: Pregnancy data come from the 2001 and 2007 DHS survey rounds and the 2003 and 2005 ZSBS survey rounds.
Number of children ever born and child mortality data come from the 2001 and 2007 DHS survey rounds.
HIV positive comes from HIV testing module in 2007 DHS.
Pregnant is an indicator variable equal to one if the respondent reported being pregnant at any time in the past twelve
months.
HIV positive is an indicator variable equal to one if the respondent tested positive.
"Under-1 child death" is an indicator variable defined as one if a child died aged 1 or younger and defined as zero if a child aged 1 or younger has not died.
KnowMTCT is an indicator variable equal to one if the respondent knows that HIV may be transmitted from mother to child.
KnowPMTCT is an indicator variable equal to one if the respondent is aware that it is possible to prevent mother-to-child transmisison of HIV.
Currently breastfeeding is an indicator variable equal to one a child age 24 months or younger is currently breastfeeding.Table 3: Mean Characteristics of Female DHS and ZSBS Respondents by Proximity to PMTCT Site
greater than 10km
Sample: of eventual PMTCT site from eventual PMTCT site
(1) (2)
Panel A: Females age 15-49
Age 27.5 28.3
Completed primary 0.64 0.37
Completed secondary 0.16 0.07
Married 0.57 0.66
Any partner 0.72 0.77
Sex in past month 0.58 0.60
Proportion unprotected sex 0.85 0.91
Pregnant 0.28 0.36
Number of children 2.74 3.40
HIV positive 0.20 0.11
Know PMTCT 0.37 0.25
Observations 10,315 7,077
Panel B: Children age 0-24 months
Breastfeeding 0.72 0.82
Under-one month mortality 0.04 0.04
Under-1 mortality 0.08 0.10
Under-2 mortality 0.11 0.11
Observations 6,322 5,682
Notes: Data come from the 2001 and 2007 DHS survey rounds and the 2003 and 2005 ZSBS survey rounds.
Data on HIV status come from a single cross-section, the 2007 DHS.
Data on child mortality from the 2001 and 2007 DHS and are child-level data.
within 10kmTable 4: Effect of Local PMTCT on Fertility
Dependent variable:
(1) (2) (3) (4)
PMTCT within 10km -0.046*** -0.039** -0.037* -0.032
(0.015) (0.019) (0.019) (0.024)
Linear trends NO YES NO YES
Controls for other HIV/AIDS services NO NO YES YES
Observations 17,392 17,392 17,392 17,392
Notes: Data come from the 2001 and 2007 DHS survey rounds and the 2003 and 2005 ZSBS survey rounds.
Pregnant is an indicator variable for being pregnant sometime in the twelve months prior to the survey date, inclusive.
"PMTCT within 10km" is an indicator variable equal to one if a health clinic with 10 kilometers of the respondent 
offered PMTCT at least twelve months prior to the survey date.
All specifications include an indicator variable for whether PMTCT was ever introduced within 10km of the respondent.
All specifications include district fixed effects and month times year fixed effects.
Standard errors are in parentheses and are clustered by Standard Enumeration Area (SEA).
*** Significant at the 1 percent level, ** Significant at the 5 percent level, * Significant at the 10 percent level.
pregnantTable 5: Dynamic Effects of Local PMTCT on Fertility
Dependent variable: pregnant
(1)
PMTCT within 10km -0.030
(0.024)
PMTCT within 10km at least thirty-six months -0.033
(0.021)
P > F(PMTCT+PMTCT at least thirty-six months=0) 0.047
Observations 17,392
Notes: Data come from the 2001 and 2007 DHS survey rounds and the 2003 and 2005 ZSBS survey rounds.
Pregnant is an indicator variable for being pregnant sometime in the twelve months prior to the survey date, inclusive.
"PMTCT within 10km" is an indicator variable equal to one if a health clinic within 10 kilometers of the respondent
offered PMTCT at least twelve months prior to the survey date.
"PMTCT within 10km at least thirty-six months" is an indicator variable equal to one if a health clinic within
10 kilometers of the respondent offered PMTCT at least thirty-six months prior to the survey date.
All specifications include an indicator variable for whether PMTCT was ever introduced within 10km of the respondent.
All specifications inlcude a secular linear trend and a separate linear trend for individuals residing with 10km of locations ever receiving PMTCT.
All specifications include controls for other HIV/AIDS services.
All specifications include district fixed effects and month times year fixed effects.
Standard errors are in parentheses and are clustered by Standard Enumeration Area (SEA).
*** Significant at the 1 percent level, ** Significant at the 5 percent level, * Significant at the 10 percent level.Table 6: Heterogeneity by HIV Prevalence in Effect of Local PMTCT
Dependent variable: pregnant
(1)
PMTCT within 10km -0.016
(0.025)
PMTCT within 10km * HIV prevalence at median or above -0.028*
(0.015)
P > F(PMTCT+PMTCT*HIV prev=0) 0.072
Observations 17,390
Notes: Data come from the 2001 and 2007 DHS survey rounds and the 2003 and 2005 ZSBS survey rounds.
Pregnant is an indicator variable for being pregnant sometime in the twelve months prior to the survey date, inclusive.
"PMTCT within 10km" is an indicator variable equal to one if a health clinic within 10 kilometers of the respondent
offered PMTCT at least twelve months prior to the survey date.
"HIV prevalence at median or above" is an indicator variable equal to one if HIV prevalence in the respondent's demographic group
is equal to or greater than median HIV prevalence in Zambia, where demographic group is defined as the interaction betweeen five
year age group and province of residence.
All specifications include an indicator variable for whether PMTCT was ever introduced within 10km of the respondent.
All specifications inlcude a secular linear trend and a separate linear trend for individuals residing with 10km of locations ever receiving PMTCT.
All specifications include controls for other HIV/AIDS services.
All specifications include district fixed effects and month times year fixed effects.
All specifications control for "HIV prevalence at median or above".
Standard errors are in parentheses and are clustered by Standard Enumeration Area (SEA).
*** Significant at the 1 percent level, ** Significant at the 5 percent level, * Significant at the 10 percent level.Table 7: Heterogeneity by Age in Effect of Local PMTCT
Dependent variable: pregnant
(1)
PMTCT within 10km -0.018
(0.027)
PMTCT within 10km * age 20-29 -0.032*
(0.019)
PMTCT within 10km * age 30-39 -0.016
(0.021)
PMTCT within 10km * age 40-49 0.011
(0.019)
P > F(PMTCT+PMTCT*age 20-29=0) 0.048
P > F(PMTCT+PMTCT*age 30-39=0) 0.229
P > F(PMTCT+PMTCT*age 40-49=0) 0.786
Observations 17,390
Notes: Data come from the 2001 and 2007 DHS survey rounds and the 2003 and 2005 ZSBS survey rounds.
Pregnant is an indicator variable for being pregnant sometime in the twelve months prior to the survey date, inclusive.
"PMTCT within 10km" is an indicator variable equal to one if a health clinic within 10 kilometers of the respondent
offered PMTCT at least twelve months prior to the survey date.
Age 15-19 is the omitted age category.
"Age 20-29" is an indicator variable equal to one if the respondent is age 20-29.
"Age 30-39" is an indicator variable equal to one if the respondent is age 30-39.
"Age 40-49" is an indicator variable equal to one if the respondent is age 40-49.
All specifications include an indicator variable for whether PMTCT was ever introduced within 10km of the respondent.
All specifications inlcude a secular linear trend and a separate linear trend for individuals residing with 10km of locations ever receiving PMTCT.
All specifications include controls for other HIV/AIDS services.
All specifications include district fixed effects and month times year fixed effects.
All specifications include controls for five-year age group.
Standard errors are in parentheses and are clustered by Standard Enumeration Area (SEA).
*** Significant at the 1 percent level, ** Significant at the 5 percent level, * Significant at the 10 percent level.Table 8: Heterogeneity by Education Level in Effect of Local PMTCT
Dependent variable: pregnant
(1)
PMTCT within 10km -0.021
(0.026)
PMTCT within 10km * completed primary school 0.002
(0.018)
PMTCT within 10km * completed secondary school -0.033
(0.022)
P > F(PMTCT+PMTCT*primary=0) 0.443
P > F(PMTCT+PMTCT*primary+PMTCT*secondary=0) 0.066
Observations 17,390
Notes: Data come from the 2001 and 2007 DHS survey rounds and the 2003 and 2005 ZSBS survey rounds.
Pregnant is an indicator variable for being pregnant sometime in the twelve months prior to the survey date, inclusive.
"PMTCT within 10km" is an indicator variable equal to one if a health clinic within 10 kilometers of the respondent 
offered PMTCT at least twelve months prior to the survey date.
All specifications include an indicator variable for whether PMTCT was ever introduced within 10km of the respondent.
All specifications inlcude a secular linear trend and a separate linear trend for individuals residing with 10km of locations ever receiving PMTCT.
All specifications include controls for other HIV/AIDS services.
All specifications include district fixed effects and month times year fixed effects.
All specifications include controls for completed primary and completed secondary school.
Standard errors are in parentheses and are clustered by Standard Enumeration Area (SEA).
*** Significant at the 1 percent level, ** Significant at the 5 percent level, * Significant at the 10 percent level.Table 9: Effect of Local PMTCT on Knowledge of PMTCT and on Breastfeeding
Dependent variable:
(1) (2) (3) (4)
PMTCT within 10km 0.048*** 0.033 0.175*** 0.171***
(0.021) (0.024) (0.045) (0.047)
PMTCT within 10km * completed primary school -0.001 0.014
(0.016) (0.036)
PMTCT within 10km * completed secondary school 0.070*** -0.012
(0.021) (0.080)
P > F(PMTCT+PMTCT*primary=0) 0.153 0.000
P > F(PMTCT+PMTCT*primary+PMTCT*secondary=0) 0.000 0.045
Observations 16,677 16,677 3,380 3,380
Notes: Data on PMTCT knowledge come from the 2001 and 2007 DHS survey rounds and the 2003 and 2005 ZSBS survey rounds.
Data on breastfeding come from the 2001 and 2007 DHS survey rounds.
Currently breastfeeding is an indicator variable equal to one a child age 24 months or younger is currently breastfeeding.
"PMTCT within 10km" is an indicator variable equal to one if a health clinic within 10 kilometers of the respondent 
offered PMTCT at least twelve months prior to the survey date.
All specifications include an indicator variable for whether PMTCT was ever introduced within 10km of the respondent.
All specifications inlcude a secular linear trend and a separate linear trend for individuals residing with 10km of locations ever receiving PMTCT.
All specifications include controls for other HIV/AIDS services.
All specifications include district fixed effects and month times year fixed effects.
Columns (2) and (4) include controls for completed primary and completed secondary school.
Standard errors are in parentheses and are clustered by Standard Enumeration Area (SEA).
*** Significant at the 1 percent level, ** Significant at the 5 percent level, * Significant at the 10 percent level.
currently breastfeeding know PMTCTTable 10: Effect of Local PMTCT on Child Survival
Dependent variable: under-one month death under-1 death under-2 death
(1) (2) (3)
PMTCT within 10km -0.028*** -0.040*** -0.022
(0.010) (0.014) (0.023)
Observations 12,004 10,474 8,848
Notes: Data come from the 2001 and 2007 DHS survey rounds.
"Under-one month child death" is an indicator variable defined as one if a child died aged 1 month or younger
and defined as zero if a child aged one month or younger has not died.
"Under-1 death" and "under-2 death" defined similarly for 24 months and 36 months, respectively.
"PMTCT within 10km" is an indicator variable equal to one if a health clinic within 10 kilometers of the
respondent offered PMTCT at least twelve months prior to the child birth date.
All specifications include an indicator variable for whether PMTCT was ever introduced within 10km of the respondent.
All specifications inlcude a secular linear trend and a separate linear trend for individuals residing with 10km of locations ever receiving PMTCT.
All specifications include controls for other HIV/AIDS services.
All specifications include district fixed effects and month times year fixed effects.
Standard errors are in parentheses and are clustered by Standard Enumeration Area (SEA).
*** Significant at the 1 percent level, ** Significant at the 5 percent level, * Significant at the 10 percent level.